RF ablation is safe, efficacious for smaller tumors
Whistler, British Columbia, Canada--Radiofrequency ablation of small renal tumors appears to be an effective nephron-sparing approach for treating localized kidney cancer in a very select group of patients using imperative indications, according to a short-term study from the University of Texas Southwestern Medical Center, Dallas.
Jessica Feehan, NP-C, discusses the expanding role of APPs in urology, from clinical leadership and procedures to care coordination and treatment initiation.
Sam S. Chang, MD, MBA, discusses treatment selection after BCG failure, including bladder-sparing options, cystectomy considerations, and the need for sequencing data.
Justin B. Ziemba, MD, discusses clinical factors that help identify patients at increased risk for kidney stone recurrence and guide metabolic evaluation.
Adam Sharp, PhD, BM, MRCP, BSc, discusses preliminary safety and efficacy findings from a phase 1/2 study of gedatolisib plus darolutamide in patients with mCRPC.